CA2437809A1 - Novel alkyl phenylimino-imidazolidine derivatives for treating urinary incontinence - Google Patents

Novel alkyl phenylimino-imidazolidine derivatives for treating urinary incontinence Download PDF

Info

Publication number
CA2437809A1
CA2437809A1 CA002437809A CA2437809A CA2437809A1 CA 2437809 A1 CA2437809 A1 CA 2437809A1 CA 002437809 A CA002437809 A CA 002437809A CA 2437809 A CA2437809 A CA 2437809A CA 2437809 A1 CA2437809 A1 CA 2437809A1
Authority
CA
Canada
Prior art keywords
phen
iminoimidazolidine
isopropyl
methyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002437809A
Other languages
English (en)
French (fr)
Inventor
Franz Esser
Pascale Pouzet
Hisato Kitagawa
Kenji Sakai
Ikunobu Muramatsu
Matthias Hoffmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2437809A1 publication Critical patent/CA2437809A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002437809A 2001-02-10 2002-01-22 Novel alkyl phenylimino-imidazolidine derivatives for treating urinary incontinence Abandoned CA2437809A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10106214.1 2001-02-10
DE10106214A DE10106214A1 (de) 2001-02-10 2001-02-10 Neue Alkyl-phenylimino-imidazolidin-Derivate zur Behandlung der Harninkontinenz
PCT/EP2002/000576 WO2002064570A1 (de) 2001-02-10 2002-01-22 Neue alkyl-phenylimino-imidazolidin-derivate zur behandlung der harninkontinenz

Publications (1)

Publication Number Publication Date
CA2437809A1 true CA2437809A1 (en) 2002-08-22

Family

ID=7673601

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002437809A Abandoned CA2437809A1 (en) 2001-02-10 2002-01-22 Novel alkyl phenylimino-imidazolidine derivatives for treating urinary incontinence

Country Status (21)

Country Link
EP (1) EP1362038A1 (hu)
JP (1) JP2004517963A (hu)
KR (1) KR20030076653A (hu)
CN (1) CN1491216A (hu)
AR (1) AR035226A1 (hu)
BG (1) BG108036A (hu)
BR (1) BR0206949A (hu)
CA (1) CA2437809A1 (hu)
CZ (1) CZ20032146A3 (hu)
DE (1) DE10106214A1 (hu)
EA (1) EA200300835A1 (hu)
EC (1) ECSP034700A (hu)
EE (1) EE200300379A (hu)
HU (1) HUP0303004A3 (hu)
IL (1) IL157297A0 (hu)
MX (1) MXPA03007127A (hu)
NO (1) NO20033368D0 (hu)
PL (1) PL362149A1 (hu)
SK (1) SK10132003A3 (hu)
WO (1) WO2002064570A1 (hu)
ZA (1) ZA200305609B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100378097C (zh) * 2003-05-09 2008-04-02 弗·哈夫曼-拉罗切有限公司 作为α-1肾上腺素能激动剂的甲基吲哚和甲基吡咯并吡啶
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202660A (en) * 1961-10-09 1965-08-24 Boehringer Sohn Ingelheim Process for the preparation of 3-arylamino-1, 3-diazacycloalkenes
HU192986B (en) * 1984-05-23 1987-08-28 Egyt Gyogyszervegyeszeti Gyar Process for production of imidasodiline derivatives
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
FR2761061B1 (fr) * 1997-03-20 1999-04-23 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives

Also Published As

Publication number Publication date
WO2002064570A1 (de) 2002-08-22
EP1362038A1 (de) 2003-11-19
SK10132003A3 (sk) 2004-02-03
AR035226A1 (es) 2004-05-05
MXPA03007127A (es) 2003-11-18
HUP0303004A3 (en) 2004-07-28
CN1491216A (zh) 2004-04-21
BG108036A (bg) 2004-12-30
NO20033368L (no) 2003-07-28
NO20033368D0 (no) 2003-07-28
EE200300379A (et) 2003-12-15
EA200300835A1 (ru) 2004-02-26
KR20030076653A (ko) 2003-09-26
DE10106214A1 (de) 2002-08-14
JP2004517963A (ja) 2004-06-17
HUP0303004A2 (hu) 2003-12-29
ECSP034700A (es) 2003-08-29
CZ20032146A3 (cs) 2003-12-17
BR0206949A (pt) 2004-02-25
IL157297A0 (en) 2004-02-19
PL362149A1 (en) 2004-10-18
ZA200305609B (en) 2004-04-29

Similar Documents

Publication Publication Date Title
CA1121820A (en) Quinazoline compounds
US4532331A (en) 1-Benzyl-2-aminomethyl imidazole derivatives
PL166214B1 (pl) Sposób wytwarzania nowych pochodnych indolu PL PL PL PL PL PL PL
KR102139905B1 (ko) [3-(1-(1h-이미다졸-4-일)에틸)-2-메틸페닐] 메탄올의 에스테르 프로드러그
HU187478B (en) Process for preparing new imidazolyl-phenyl-amidines and pharmaceutical compositions containing thereof
IE59141B1 (en) N-substituted 2-amino-thiazoles, process for their preparation and their therapeutic application
US4835154A (en) 1-aralykyl-5-piperazinylmethyl-2-mercaptoimidazoles and 2-alkylthioimidazoles and their use as dopamine-βhydroxylase inhibitors
US4719223A (en) Imidazolethiol dopamine-beta-hydroxylase inhibitors
CA2437809A1 (en) Novel alkyl phenylimino-imidazolidine derivatives for treating urinary incontinence
US4935438A (en) Dopamine-β-hydroxylase inhibitors
US20020169193A1 (en) Alkylphenyliminoimidazolidine derivatives for treating urinary incontinence
US6602897B2 (en) m-Amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
KR900000671B1 (ko) 2,2'-바이-1h-이미다졸 및 그의 제조방법
CA2425563A1 (en) Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
PL208284B1 (pl) Pochodne benzo[g]chinoliny, kompozycje je zawierające oraz zastosowanie takich pochodnych
RU2481335C2 (ru) Производные дигидроимидазола, замещенного конденсированным карбоциклом, используемые для снятия боли и лечения состояний, подобных глаукоме
US5036086A (en) Novel benzothiazole derivatives
PT1480970E (pt) Derivados de quinolina
US4873357A (en) Trifluoro acetyl-cyano-aniline intermediates for dopamine-βhydroxylase inhibitors
US4772723A (en) Dopamine β-hydroxylase inhibitors
US4863944A (en) Dopamine-β-hydroxylase inhibitors
US4912226A (en) Intermediate to dopamine-β-hydroxylase inhibitors

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued